Center for Scientific Review; Notice of Closed Meetings, 10490-10491 [2017-02845]
Download as PDF
10490
Federal Register / Vol. 82, No. 28 / Monday, February 13, 2017 / Notices
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
AGENCY:
[FR Doc. 2017–02878 Filed 2–10–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jstallworth on DSK7TPTVN1PROD with NOTICES
Advisory Committee on Immunization
Practices (ACIP)
Correction: This notice was published
in the Federal Register on January 25,
2017, Volume 82, Page 8427. The
Matters for Discussion should read as
follows:
Matters for Discussion: The agenda
will include discussions on:
Meningococcal vaccine; influenza;
hepatitis B vaccine; herpes zoster
vaccine; vaccine safety; yellow fever
vaccine; Zika virus vaccine; mumps
outbreak; Dengue virus vaccines; Polio
Eradication Initiative; Measles and
Rubella Elimination Initiative; adult
immunization and vaccine supply. A
recommendation vote is scheduled for
hepatitis B vaccine A Vaccines for
Children (VFC) vote is scheduled for
hepatitis B vaccine.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30329, telephone 404/
639–8836; Email ACIP@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
VerDate Sep<11>2014
13:41 Feb 10, 2017
Jkt 241001
Meeting of the Advisory Committee on
Training in Primary Care Medicine and
Dentistry
Health Resources and Service
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
In accordance with the
Federal Advisory Committee Act, notice
is hereby given that a meeting is
scheduled for the Advisory Committee
on Training in Primary Care Medicine
and Dentistry (ACTPCMD). This
meeting will be open to the public.
Information about ACTPCMD and the
agenda for this meeting can be obtained
by accessing the ACTPCMD Web site at
https://www.hrsa.gov/
advisorycommittees/bhpradvisory/
ACTPCMD.
SUMMARY:
BILLING CODE 4163–18–P
[FR Doc. 2017–02879 Filed 2–10–17; 8:45 am]
Health Resources and Services
Administration
March 6, 2017, 9:00 a.m.–5:00
p.m. ET and March 7, 2017, 8:30 a.m.–
5:00 p.m. ET
ADDRESSES: This meeting will be held in
person and offer virtual access through
teleconference and webinar. The
address for the meeting is 5600 Fishers
Lane, Rockville, Maryland 20857.
• The conference call-in number is 1–
800–619–2521. Passcode: 9271697.
• The webinar link is https://
hrsa.connectsolutions.com/actpcmd.
Status: This advisory committee
meeting will be open to the public.
FOR FURTHER INFORMATION CONTACT:
Anyone requesting information
regarding ACTPCMD should contact Dr.
Kennita Carter, Designated Federal
Official, Division of Medicine and
Dentistry, Bureau of Health Workforce,
HRSA, in one of three ways: (1) Send a
request to the following address: Dr.
Kennita Carter, Designated Federal
Official, Division of Medicine and
Dentistry, HRSA, 5600 Fishers Lane,
15N–116, Rockville, Maryland 20857;
(2) call 301–945–3505; or (3) send an
email to KCarter@hrsa.gov.
SUPPLEMENTARY INFORMATION: The
ACTPCMD provides advice and
recommendations to the Secretary of
HHS (Secretary) on policy, program
development, and other matters of
significance concerning the activities
under sections 747 and 748 of title VII
of the Public Health Service Act (PHS
Act). The ACTPCMD prepares an annual
report describing the activities of the
Committee, including findings and
recommendations made by the
DATES:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Committee regarding the activities
under sections 747 and 748. The annual
report is submitted to the Secretary, and
Chairmen and ranking members of the
Senate Committee on Health, Education,
Labor and Pensions and the House of
Representatives Committee on Energy
and Commerce. The Committee also
develops, publishes, and implements
performance measures and guidelines
for longitudinal evaluations for
programs authorized under Part C of
Title VII of the PHS Act, and
recommends appropriation levels for
programs under this Part.
During the March 6–7, 2017 meeting,
the ACTPCMD will discuss issues
related to the Committee report on the
integration of behavioral health into
primary care and oral health training;
and clinical trainee and faculty wellbeing and resiliency. Agenda items are
subject to change.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to make oral comments or
provide written comments to the
ACTPCMD should be sent to Dr.
Kennita Carter, Designated Federal
Official, using the contact information
above at least 3 business days prior to
the meeting.
The 5600 Fishers Lane building
requires a security screening on entry.
To facilitate your access to the building,
please contact Dr. Kennita Carter at the
contact information listed above.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify Dr. Kennita Carter at least 10 days
prior to the meeting.
Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017–02833 Filed 2–10–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\13FEN1.SGM
13FEN1
Federal Register / Vol. 82, No. 28 / Monday, February 13, 2017 / Notices
jstallworth on DSK7TPTVN1PROD with NOTICES
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR
Panel—Education and Health: New Frontiers.
Date: February 28, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Gabriel B. Fosu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
MSC 7808, Bethesda, MD 20892, (301) 435–
3562, fosug@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Emphasis Panel: Cardiovascular and
Respiratory AREA.
Date: March 1–2, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4128,
Bethesda, MD 20892, 301–435–1850, limc4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–
326: Advancing Basic Behavioral and Social
Research on Resilience.
Date: March 3, 2017.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John H. Newman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 435–
0628, newmanjh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
260: Methodology and Measurement in the
Behavioral and Social Sciences Special
Emphasis Panel.
Date: March 6, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
VerDate Sep<11>2014
13:41 Feb 10, 2017
Jkt 241001
Contact Person: Karin F. Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 254–
9975, helmersk@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group; AIDS
Clinical Studies and Epidemiology Study
Section.
Date: March 6–7, 2017.
Time: 8:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: Dimitrios Nikolaos
Vatakis, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3190, Bethesda, MD 20892, 301–827–
7480.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Physical Activity and Weight Control
Interventions Among Cancer Survivors:
Effects on Biomarkers of Prognosis and
Survival.
Date: March 6, 2017.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Denise Wiesch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3138,
MSC 7770, Bethesda, MD 20892, (301) 437–
3478, wieschd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Lung injury
and breathing control.
Date: March 7–8, 2017.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: George M. Barnas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4220,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Harnessing
Big Data to Halt HIV.
Date: March 7, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
Contact Person: Dimitrios Nikolaos
Vatakis, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3190, Bethesda, MD 20892, 301–827–
7480.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cellular and Molecular
Immunology.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
10491
Date: March 8, 2017.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Tina McIntyre, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892, 301–594–
6375, mcintyrt@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 7, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02845 Filed 2–10–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Bold New Bioengineering Concepts and
Approaches.
Date: March 7, 2017.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Kristin Goltry, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7198, Bethesda, MD 20892, 301–827–7930,
goltrykl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
E:\FR\FM\13FEN1.SGM
13FEN1
Agencies
[Federal Register Volume 82, Number 28 (Monday, February 13, 2017)]
[Notices]
[Pages 10490-10491]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02845]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections
[[Page 10491]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel--Education and Health: New Frontiers.
Date: February 28, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Gabriel B. Fosu, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108, MSC 7808, Bethesda, MD
20892, (301) 435-3562, fosug@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Special Emphasis Panel: Cardiovascular and Respiratory AREA.
Date: March 1-2, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Center for Scientific Review,
National Institutes of Health, 6701 Rockledge Drive, Room 4128,
Bethesda, MD 20892, 301-435-1850, limc4@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 16-326: Advancing Basic Behavioral and Social Research on
Resilience.
Date: March 3, 2017.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John H. Newman, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD
20892, (301) 435-0628, newmanjh@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-16-260: Methodology and Measurement in the Behavioral and
Social Sciences Special Emphasis Panel.
Date: March 6, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Karin F. Helmers, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD
20892, (301) 254-9975, helmersk@csr.nih.gov.
Name of Committee: AIDS and Related Research Integrated Review
Group; AIDS Clinical Studies and Epidemiology Study Section.
Date: March 6-7, 2017.
Time: 8:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street NW.,
Washington, DC 20037.
Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3190, Bethesda, MD 20892, 301-
827-7480.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Physical Activity and Weight Control Interventions
Among Cancer Survivors: Effects on Biomarkers of Prognosis and
Survival.
Date: March 6, 2017.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Denise Wiesch, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3138, MSC 7770, Bethesda, MD 20892, (301) 437-
3478, wieschd@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Lung injury and breathing control.
Date: March 7-8, 2017.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: George M. Barnas, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4220, MSC 7818, Bethesda, MD
20892, 301-435-0696, barnasg@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Harnessing Big Data to Halt HIV.
Date: March 7, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street NW.,
Washington, DC 20037.
Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3190, Bethesda, MD 20892, 301-
827-7480.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cellular and Molecular Immunology.
Date: March 8, 2017.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Tina McIntyre, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4202, MSC 7812, Bethesda, MD 20892, 301-594-
6375, mcintyrt@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 7, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02845 Filed 2-10-17; 8:45 am]
BILLING CODE 4140-01-P